SLC/CCL21-mediated anti-tumor responses require IFNγ, MIG/CXCL9 and IP-10/CXCL10

Molecular Cancer

Volumn 2, Issue , 2003, Pages

  Sharma, Sherven ^a,b   Yang, Seok Chul ^a   Hillinger, Sven ^a   Zhu, Li X ^a   Huang, Min ^a   Batra, Raj K ^a,b   Lin, Jeff F ^a   Burdick, Marie D ^a   Strieter, Robert M ^a   Dubinett, Steven M ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; SECONDARY LYMPHOID TISSUE CHEMOKINE; UNCLASSIFIED DRUG; ALPHA CHEMOKINE; BETA CHEMOKINE; CCL21C PROTEIN, MOUSE; CXCL9 CHEMOKINE; CXCL9 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFICACY; DRUG POTENCY; IN VIVO STUDY; LUNG CANCER; MOUSE; NONHUMAN; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE; TUMOR LOCALIZATION; TUMOR VOLUME; ANIMAL; C57BL MOUSE; CANCER TRANSPLANTATION; GENETICS; IMMUNOLOGY; LEWIS CARCINOMA; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

ANIMALS; CARCINOMA, LEWIS LUNG; CELL LINE, TUMOR; CHEMOKINE CCL21; CHEMOKINE CXCL10; CHEMOKINE CXCL9; CHEMOKINES, CC; CHEMOKINES, CXC; INTERFERON-GAMMA; MICE; MICE, INBRED C57BL; NEOPLASM TRANSPLANTATION;

EID: 0242350415     PISSN: 14764598     EISSN: None     Source Type: Journal    
DOI: 10.1186/1476-4598-2-22     Document Type: Article

References (33)

1. Cyster J G Chemokines and the Homing of Dendritic Cells to the T Cell Areas of Lymphoid Organs J Exp Med 1999, 189:447-450
2. Ogata M, Zhang Y, Wang Y, Itakura M, Zhang Y, Harada A, Hashimoto S and Matsushima K Chemotactic Response Toward Chemokines and Its Regulation by Transforming Growth Factor-beta1 of Murine Bone Marrow Hematopoietic Progenitor Cell-Derived Different Subset of Dendritic Cells Blood 1999, 93:3225-3232
3. Chan VW, Kothakota S, Rohan MC, Panganiban-Lustan L, Gardner JP, Wachowicz MS, Winter JA and Williams LT Secondary lymphoid-tissue chemokine (SLC) is chemotactic for mature dendritic cells Blood 1999, 93:3610-6
4. Hedrick JA and Zlotnik A Identification and characterization of a novel beta chemokine containing six conserved cysteines J Immunol 1997, 159:1589-93
5. Hromas R, Kim CH, Klemsz M, Krathwohl M, Fife K, Cooper S, Schnizlein-Bick C and Broxmeyer HE Isolation and characterization of Exodus-2, a novel C-C chemokine with a unique 37-amino acid carboxyl-terminal extension J Immunol 1997, 159:2554-8
6. Nagira M, Imai T, Yoshida R, Takagi S, Iwasaki M, Baba M, Tabira Y, Akagi J, Nomiyama H and Yoshie O A lymphocyte-specific CC chemokine, secondary lymphoid tissue chemokine (SLC), is a highly efficient chemoattractant for B cells and activated T cells Eur J Immunol 1998, 28:1516-23
7. Tanabe S, Lu Z, Luo Y, Quackenbush EJ, Berman MA, Collins-Racie LA, Mi S, Reilly C, Lo D, Jacobs KA and Dorf ME Identification of a new mouse beta-chemokine, thymus-derived chemotactic agent 4, with activity on T lymphocytes and mesangial cells J Immunol 1997, 159:5671-9
8. Willimann K, Legler DF, Loetscher M, Roos RS, Delgado MB, Clark-Lewis I, Baggiolini M and Moser B The chemokine SLC is expressed in T cell areas of lymph nodes and mucosal lymphoid tissues and attracts activated T cells via CCR7 Eur J Immunol 1998, 28:2025-34
9. Sharma S, Stolina M, Luo J, Strieter RM, Burdick M, Zhu LX, Batra RK and Dubinett SM Secondary lymphoid tissue chemokine mediates T cell-dependent antitumor responses in vivo J Immunol 2000, 164:4558-63
10. Sharma S, Stolina M, Zhu L, Lin Y, Batra R, Huang M, Strieter R and Dubinett S Secondary Lymphoid Organ Chemokine Reduces Pulmonary Tumor Burden in Spontaneous Murine Bronchoalveolar Cell Carcinoma Cancer Research 2001, 61:6406-6412
11. Taub DD, Lloyd AR, Conlon K, Wang JM, Ortaldo JR, Harada A, Matsushima K, Kelvin DJ and Oppenheim JJ Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells J Exp Med 1993, 177:1809-14
12. Liao F, Rabin RL, Yannelli JR, Koniaris LG, Vanguri P and Farber JM Human Mig chemokine: biochemical and functional characterization J Exp Med 1995, 182:1301-14
13. Loetscher M, Gerber B, Loetscher P, Jones SA, Piali L, Clark-Lewis I, Baggiolini M and Moser B Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes [see comments] J Exp Med 1996, 184:963-9
14. Strieter RM, Kunkel SL, Arenberg DA, Burdick MD and Polverini PJ Interferon gamma-inducible protein 10 (IP-10), a member of the C-X-C chemokine family, is an inhibitor of angiogenesis Biochem Biophys Res Commun 1995, 210:51-7
15. Addison C, Arenberg D, Morris S, Xue Y, Burdick M, Mulligan M, Iannettoni M and Strieter R The CXC chemokine, monokine induced by interferon gamma, inhibits non-small cell lung carcinoma tumor growth and metastasis Hum Gene Ther 2000, 11:247-61
16. Tannenbaum CS, Tubbs R, Armstrong D, Finke JH, Bukowski RM and Hamilton TA The CXC chemokines IP-10 and Mig are necessary for IL-12-mediated regression of the mouse RENCA tumor J Immunol 1998, 161:927-32
17. Arenberg DA, Kunkel SL, Polverini PJ, Morris SB, Burdick MD, Glass MC, Taub DT, Iannettoni MD, Whyte RI and Strieter RM Interferon-gamma-inducible protein 10 (IP-10) is an angiostatic factor that inhibits human non-small cell lung cancer (NSCLC) tumorigenesis and spontaneous metastases J Exp Med 1996, 184:981-92
18. Kanegane C, Sgadari C, Kanegane H, Feldstein tJ, Yao L, Gupta G, Farber JM, Liao F, Liu L and Tosato G Contribution of the CXC chemokines IP-10 and Mig to theantitumor effects of IL-12 J Leukocyte Biol 1998, 64:384
19. Pertl U, Luster AD, Varki NM, Homann D, Gaedicke G, Reisfeld RA and Lode HN IFN-gamma-inducible protein-10 is essential for the generation of a protective tumor-specific CD8 T cell response induced by single-chain IL-12 gene therapy J Immunol 2001, 166:6944-51
20. Huang AYC, Golumbek P, Ahmadzadeh M, Jaffee E, Pardoll D and Levitsky H Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens Science 1994, 264:961-965
21. Gabrilovich DI, Chen HL, Girgis KR, Cunningham HT, Meny GM, Nadaf S, Kavanaugh D and Carbone DP Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells Nat Med 1996, 2:1096-103
22. Qin Z, Noffz G, Mohaupt M and Blankenstein T Interleukin-10 prevents dendritic cell accumulation and vaccination with granulocyte-macrophage colony-stimulating factor gene-modified tumor cells J Immunol 1997, 159:770-776
23. Gabrilovich DI, Corak J, Ciernik IF, Kavanaugh D and Carbone DP Decreased antigen presentation by dendritic cells in patients with breast cancer Clin Cancer Res 1997, 3:483-90
24. Gabrilovich D, Ishida T, Oyama T, Ran S, Kravtsov V, Nadaf S and Carbone DP Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo Blood 1998, 92:4150-66
25. Arenberg DA, Zlotnick A, Strom SRB, Burdick MD and Strieter RM The murine CC chemokine, 6Ckine, inhibits tumor growth and angiogenesis in a human lung cancer SCID mouse model Cancer Immunology Immunotherapy 2000, 49:587-592
26. Vicari AP, Yahia SA, Chemin K, Mueller A, Zlotnik A and Caux C Antitumor effects of the Mouse Chemokine 6Ckine/SLC through angiostatic and Immunological mechanisms J Immunol 2000, 165:1992-2000
27. Kirk CJ, Hartigan-O'Connor D, Nickoloff BJ, Chamberlain JS, Giedlin M, Aukerman L and Mule JJ T cell-dependent antitumor immunity mediated by secondary lymphoid tissue chemokine: augmentation of dendritic cell-based immunotherapy Cancer Res 2001, 61:2062-70
28. Soto H, Wang W, Strieter RM, Copeland NG, Gilbert DJ, Jenkins NA, Hedrick J and Zlotnik A The CC chemokine 6Ckine binds the CXC chemokine receptor CXCR3 Proc Natl Acad Sci U S A 1998, 95:8205-10
29. Arenberg D, Zlotnick A, Strom S, Burdick M and Strieter R Inhibition of lung cancer growth by the novel chemokine 6C-kine Am J Resp Crit Care Med 1999, 159:A746
30. Farber JM Mig and IP-10: CXC chemokines that target lymphocytes J Leukoc Biol 1997, 61:246-57
31. Belperio JA, Keane MP, Burdick MD, Lynch JP 3rd, Xue YY, Li K, Ross DJ and Strieter RM Critical role for CXCR3 chemokine biology in the pathogenesis of bronchiolitis obliterans syndrome J Immunol 2002, 169:1037-49
32. Spitalny GL and Havell EA Monoclonal antibody to murine gamma interferon inhibits lymphokine-induced antiviral and macrophage tumoricidal activities J Exp Med 1984, 159:1560-5
33. Standiford TJ, Kunkel SL, Basha MA, Chensue SW, III JPL, Toews GB, Westwick J and Strieter RM Interleukin-8 gene expression by a pulmonary epithelial cell line: A model for cytokine networks in the lung J Clin Invest 1953, 86:1945-1990